Compare Abbott Laboratories (ABT) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs PayPal Holdings, Inc. — how do they compare? Abbott Laboratories trades at $95.16 (market cap $166.94B), while PayPal Holdings, Inc. trades at $44.23 (market cap $40.27B). The key difference: Abbott Laboratories is far larger — about 4.1× PayPal Holdings, Inc.'s market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | PYPL | |
|---|---|---|
Market Cap | $166.94B | $40.27B |
Sector | Health | Financials |
52-Week High | $136.62 | $78.22 |
52-Week Low | $82.57 | $39.08 |
Enterprise Value | $193.69B | $40.34B |
Dividend Yield | 2.63% | 1.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
PayPal trades at $45.65, up 0.4% with a bullish technical outlook. The stock appears undervalued with a P/E of 8.46 and strong profitability metrics including 15% net income margin and 25.12% ROE. Recent earnings beat expectations in Q1 2026, and the company maintains robust cash flow generation of $6.4B from operations. Analyst consensus is mixed with 37% buy ratings but a $49 price target suggesting 7% upside potential.
PayPal presents a value opportunity with attractive valuation multiples and solid fundamentals, though growth moderation and competitive pressures remain concerns. The stock's technical strength and dividend initiation provide support, while legal scrutiny and execution risks warrant monitoring. Upside appears limited near-term but long-term prospects remain favorable if management delivers on growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
